[Federal Register Volume 85, Number 51 (Monday, March 16, 2020)]
[Notices]
[Page 14945]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05259]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Breast Cancer in Young Women (ACBCYW)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Advisory Committee on Breast
Cancer in Young Women (ACBCYW). This meeting is open to the public,
limited only by audio and web conference lines (80 audio and web
conference lines are available). The public is welcome to listen to the
meeting by accessing the teleconference number 1-888-606-5944, and the
passcode is 8340472, (80 lines are available). The web conference
access is https://adobeconnect.cdc.gov/rwa641n3jrry/. Online
Registration Required: All ACBCYW meeting participants must register
for the meeting online at least 5 business days in advance at https://wwwdev.cdc.gov/cancer/breast/what_cdc_is_doing/conference.htm. Please
complete all the required fields before submitting your registration
and submit no later than May 7, 2020.
DATES: The meeting will be held on May 13, 2020, from 8:00 a.m. to 1:00
p.m., EDT.
ADDRESSES: The teleconference access is 1-888-606-5944, and the
passcode is 8340472. The web conference access is https://adobeconnect.cdc.gov/rwa641n3jrry/.
FOR FURTHER INFORMATION CONTACT: Jeremy McCallister, Designated Federal
Officer, National Center for Chronic Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway NE, Mailstop S107-4, Atlanta,
Georgia 30341; Telephone: (404) 639-7989, Fax: (770) 488-4760; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The committee provides advice and guidance to the
Secretary, HHS; the Assistant Secretary for Health; and the Director,
CDC, regarding the formative research, development, implementation and
evaluation of evidence-based activities designed to prevent breast
cancer (particularly among those at heightened risk) and promote the
early detection and support of young women who develop the disease. The
advice provided by the Committee will assist in ensuring scientific
quality, timeliness, utility, and dissemination of credible appropriate
messages and resource materials.
Matters To Be Considered: The agenda will include discussions on
current topics related to breast cancer in young women. These will
include Mental/Behavioral Health, Sexual Health, Genetics and Genomics,
and Provider Engagement. Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-05259 Filed 3-13-20; 8:45 am]
BILLING CODE 4163-18-P